-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk Launches Weight-loss Pill in US

MT Newswires·01/05/2026 07:10:08
Listen to the news
07:10 AM EST, 01/05/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) launched its weight-loss pill Wegovy in the US starting from $149 per month for 1.5 milligram and 4 mg doses for self-paying customers, according to a Monday notice published on its website. The price of the 4 mg dose will increase from April 15. The Danish drugmaker is also offering two higher doses at $299. The drug was approved for weight loss by the US Food and Drug Administration in December 2025.